ISpecimen Company Insiders
ISPC Stock | USD 1.48 0.06 3.90% |
ISpecimen employs about 53 people. The company is managed by 14 executives with a total tenure of roughly 124 years, averaging almost 8.0 years of service per executive, having 3.79 employees per reported executive. Evaluation of ISpecimen's management performance can provide insight into the firm performance.
ISpecimen |
ISpecimen Management Team Effectiveness
The company has return on total asset (ROA) of (0.4426) % which means that it has lost $0.4426 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0934) %, meaning that it created substantial loss on money invested by shareholders. ISpecimen's management efficiency ratios could be used to measure how well ISpecimen manages its routine affairs as well as how well it operates its assets and liabilities.ISpecimen Workforce Comparison
iSpecimen is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 4,140. ISpecimen claims roughly 53.0 in number of employees contributing just under 2% to equities under Health Care industry.
The company has Profit Margin (PM) of (0.92) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.64) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.64. ISpecimen Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ISpecimen insiders, such as employees or executives, is commonly permitted as long as it does not rely on ISpecimen's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, ISpecimen insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Obf Investments, Llc over two weeks ago Acquisition by Obf Investments, Llc of 119035 shares of ISpecimen at 666603.0 subject to Rule 16b-3 | ||
Ross Andrew L. over a month ago Acquisition by Ross Andrew L. of 10000 shares of ISpecimen at 1.41 subject to Rule 16b-3 | ||
Ross Andrew L. over two months ago Acquisition by Ross Andrew L. of 86438 shares of ISpecimen at 562375.0 subject to Rule 16b-3 | ||
Lim Robert Bradley over two months ago Insider Trading | ||
Scholl George H. over three months ago Acquisition by Scholl George H. of 13525 shares of ISpecimen at 8.0 subject to Rule 16b-3 | ||
Basile Joseph J. over three months ago Disposition of 1668 shares by Basile Joseph J. of ISpecimen at 1.5 subject to Rule 16b-3 | ||
Field Katharyn over three months ago Insider Trading | ||
Basile Joseph J. over three months ago Acquisition by Basile Joseph J. of tradable shares of ISpecimen subject to Rule 16b-3 |
ISpecimen Notable Stakeholders
An ISpecimen stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ISpecimen often face trade-offs trying to please all of them. ISpecimen's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ISpecimen's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Robert Lim | Treasurer, CEO | Profile | |
Emily Hubbard | VP Devel | Profile | |
Benjamin Bielak | Chief Secretary | Profile | |
Eric Langlois | Chief Officer | Profile | |
Dawn Michelle | VP Operations | Profile | |
Yuying Liang | Chief Officer | Profile | |
Annette Arnold | Vice Development | Profile | |
Tracy Curley | Treasurer CFO | Profile | |
Brielan Smiechowski | Senior Development | Profile | |
Carly Lejnieks | Vice Marketing | Profile | |
Leslie Hoyt | Senior Operations | Profile | |
Jill Mullan | S Director | Profile | |
David MD | Chief Officer | Profile | |
Evan Cox | Senior Innovation | Profile |
About ISpecimen Management Performance
The success or failure of an entity such as iSpecimen often depends on how effective the management is. ISpecimen management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ISpecimen management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ISpecimen management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. The company was incorporated in 2009 and is headquartered in Lexington, Massachusetts. Ispecimen operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.
Please note, the presentation of ISpecimen's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ISpecimen's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ISpecimen's management manipulating its earnings.
ISpecimen Workforce Analysis
Traditionally, organizations such as ISpecimen use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ISpecimen within its industry.ISpecimen Manpower Efficiency
Return on ISpecimen Manpower
Revenue Per Employee | 187.3K | |
Revenue Per Executive | 709.2K | |
Net Loss Per Employee | 209.4K | |
Net Loss Per Executive | 792.8K | |
Working Capital Per Employee | 41.3K | |
Working Capital Per Executive | 156.4K |
Complementary Tools for ISpecimen Stock analysis
When running ISpecimen's price analysis, check to measure ISpecimen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ISpecimen is operating at the current time. Most of ISpecimen's value examination focuses on studying past and present price action to predict the probability of ISpecimen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ISpecimen's price. Additionally, you may evaluate how the addition of ISpecimen to your portfolios can decrease your overall portfolio volatility.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Stocks Directory Find actively traded stocks across global markets | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |